Monday, June 16, 2008

Digitek Digoxin Recalled Due to Manufacturing Defect

Digitek Digoxin Recalled Due to Manufacturing Defect
Digoxin, also known as Digitalis, Lanoxin, Digitek, and
Lanoxicaps, is a refined plant extract, a purified cardiac
glycoside(drugs used in the treatment of congestive heart
failure and arrythmia.

It is widely used in the treatment of various heart
conditions, namely atrial fibrilation and atrial flutter,
both abnormal heart rhythms It is sometimes prescribed for
heart failure that cannot be controlled by other medication.

Digoxin is commonly marketed under the name Lanoxin,
Digitek, and Lanoxicaps, and has been manufactured widely
in the United States by the pharmaceutical company Actavis
Totowa LLC, formerly known as formerly known as Amide
Pharmaceutical, Inc.

It is the New Jersey headquartered and United States based
manufacturing division of the international pharmaceutical
company Actavis Group, a well known manufacturer and
distributor of generic versions of previously name-brand
drugs. Digitek Recall

On April 25, 2008, Actavis Totowa initiated a Class 1
nationwide recall of Digitek (digoxin tablets, USP, all
strengths) for oral use. The products are distributed by
Mylan Pharmaceuticals, Inc. under a "Bertek" label and by
UDL Laboratories, Inc. under a "UDL" label. According to
the Actavis website:

The voluntary all-lot recall is due to the possibility that
tablets with double the appropriate thickness may have been
commercially released. These tablets may contain twice the
approved level of active ingredient than is appropriate.

Digitek Side Effects

The posting indicates, as do other reports, that both of
the Mylan Pharmaceuticals laboratories(Bertek and UDL)
incorrectly manufactured the Digitek pills with double the
amount of active medicine, spiking the risk of side effects
dramatically.

Common side effects include: loss of appetite, nausea,
vomiting, diarrhea, blurred vision, visual disturbances
(yellow-green halos), confusion, drowsiness, dizziness,
nightmares, agitation, and/or depression. Less frequent
adverse effects include: acute psychosis, delirium,
amnesia, and the possibility of life-threatening heart
complications, including additional arrythmia episodes and
heart failure. Additionally, Digitek has been shown to be
deadly in overdose situations.

Digitek Lawsuits

Indeed, several postings on consumer health and recall
websites reflect the outrage over this egregious error.
Reports of illnesses, complications and even deaths
consistent with the relevant side effects of overdosing
have been surfacing in the press over the last month.

These reports, coupled with the Class 1 nationwide recall
of all Digoxin tablets distributed by Mylan
Pharmaceuticals, and the additional reports released by the
FDA and other independent health care professionals lead to
a sincere possibility of a Class Action or Mass Tort
lawsuit.

In fact, several law firms have already reported the
beginnings of proceedings in such cases where overdoses
from Digoxin have injured clients and caused dangerous,
damaging, or deadly side effects.


----------------------------------------------------
For more on the Digitek digoxin toxicity, visit
http://digitek-digoxin.legalview.com/ . Also, use the
LegalView homepage at http://www.LegalView.com to peruse
other controversial prescription drug sites and learn about
the Chantix side effects or the potential for a Levaquin
class action lawsuit.

No comments: